Literature DB >> 11320403

Gene therapy effectiveness differs for neuronal survival and behavioral performance.

R G Phillips1, M L Monje, L C Giuli, T J Meier, M A Yenari, D Kunis, R M Sapolsky.   

Abstract

If neuronal gene therapy is to be clinically useful, it is necessary to demonstrate neuroprotection when the gene is introduced after insult. We now report equivalent neuronal protection if calbindin D(28K) gene transfer via herpes simplex virus amplicon vector occurs immediately, 30 min, or 1 h after an excitotoxic insult, but not after a 4 h delay. Behavioral performance was evaluated for immediate and 1 h delay groups using a hippocampal-dependent task. Despite equivalent magnitude and pattern of sparing of neurons with the immediate and 1 h delay approaches, the delay animals took a significantly longer time after insult to return to normal performance.

Mesh:

Substances:

Year:  2001        PMID: 11320403     DOI: 10.1038/sj.gt.3301397

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  4 in total

Review 1.  The potential application of gene therapy in the treatment of traumatic brain injury.

Authors:  Fang Shen; Liang Wen; Xiaofeng Yang; Weiguo Liu
Journal:  Neurosurg Rev       Date:  2007-08-09       Impact factor: 3.042

2.  Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.

Authors:  Kevin L Ju; Nathan C Manley; Robert M Sapolsky
Journal:  Exp Neurol       Date:  2007-12-23       Impact factor: 5.330

3.  Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury.

Authors:  M L Degeorge; D Marlowe; E Werner; K E Soderstrom; M Stock; A Mueller; M C Bohn; D A Kozlowski
Journal:  Brain Res       Date:  2011-06-02       Impact factor: 3.252

4.  Characterization of calretinin I-II as an EF-hand, Ca2+, H+-sensing domain.

Authors:  Malgorzata Palczewska; Gyula Batta; Patrick Groves; Sara Linse; Jacek Kuznicki
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.